eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » European Bioanalysis Forum - Interest Group Macromolecules - Comment

European Bioanalysis Forum - Interest Group Macromolecules - Comment

Document ID: FDA-2009-D-0539-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 30 2010, at 06:36 AM Eastern Standard Time
Date Posted: February 1 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: December 4 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: February 2 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a85fb1
View Document:  View as format xml

View Comment

European Bioanalysis Forum - Interest Group Macromolecules (EBF-IGM): EBF-IGM thanks the FDA for providing a long-awaited document in an area where no or little regulatory advice is available. EBF-IGM welcomes the opportunity to provide FDA with comments on this draft guideline. The consolidated opinion of 13 EBF-IGM member companies* is summarized in the document attached.

Attachments:

European Bioanalysis Forum - Interest Group Macromolecules - Comment

Title:
European Bioanalysis Forum - Interest Group Macromolecules - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 13
Novo Nordisk Inc. - Comment
Public Submission    Posted: 01/27/2010     ID: FDA-2009-D-0539-0004

Feb 02,2010 11:59 PM ET
MedImmune - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0539-0005

Feb 02,2010 11:59 PM ET
Covance Laboratories Inc. - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0539-0010

Feb 02,2010 11:59 PM ET
Amgen, Inc. - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0539-0011

Feb 02,2010 11:59 PM ET
Facet Biotech - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0539-0015

Feb 02,2010 11:59 PM ET